November 5, 2018 / 9:09 PM / 15 days ago

Mylan's quarterly revenue falls 4 pct

Nov 5 (Reuters) - Drugmaker Mylan NV reported a 4 percent fall in third-quarter revenue on Monday, hit by low prices of generic drugs in the United States and a continuing global shortage of its emergency allergy injection EpiPen.

The company’s net earnings rose to $176.7 million, or 34 cents per share, in the quarter ended Sept. 30, from $88.3 million, or 16 cents per share, a year earlier.

Total revenue fell to $2.86 billion from $2.99 billion. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below